Subscribe / Renew
|► Subscribe to our Free Weekly Newsletter|
|print email to a friend reprints add to mydjc|
September 10, 2020
Accelerator Life Science Partners, a early-stage life science management and venture capital firm, announced the expansion of its advisory teams. Kevin Chow, Ph.D. and Melissa Yeager have been named as operating partners; Scott Brun, M.D. and David Hirsh, Ph.D., have been appointed to the clinical and scientific advisory board; Jan Lundberg, Ph.D. has been appointed to the clinical and scientific advisory board and will serve as a senior advisor; and Eugene Yeo, Ph.D., will serve as a senior advisor. Chow and Yeager will join a group of operating partners to assist with the evaluation of new business opportunities, support current and future ALSP portfolio companies and serve in a variety of operating and advisory roles. Brun served in various scientific & leadership roles for over 20 years at Abbott and AbbVie. Hirsh is a professor in the department of biochemistry and molecular biophysics in the College of Physicians and Surgeons of Columbia University, where he also served as department chairman and subsequently was appointed Columbia University's first executive vice president for research. Lundberg has over two decades as head of research at AstraZeneca and head of research and development at Eli Lilly.